Get the Stockscreener App
9.64
0.52%
0.05
After Hours:
9.40
-0.24
-2.49%
Amicus Therapeutics Inc Stock (FOLD) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
4.07%
110.40
|
115.08 | 103.50 | 94.50 | 86.27 |
| Cost Of Revenue |
19.81%
13.57
|
11.32 | 9.946 | 9.114 | 6.942 |
| Gross Profit |
6.67%
96.84
|
103.76 | 93.56 | 85.39 | 79.33 |
Operating Expenses
|
15.92%
124.56
|
107.45 | 110.58 | 104.25 | 116.96 |
| Interest Income/Expense |
3.05%
12.44
|
12.83 | 12.99 | 12.49 | 11.84 |
| Benefits Costs and Expenses |
4.94%
153.99
|
146.74 | 128.21 | 135.02 | 139.49 |
| Costs And Expenses |
4.94%
153.99
|
146.74 | 128.21 | 135.02 | 139.49 |
| Operating Income/Loss |
650.84%
-27.72
|
-3.692 | -17.02 | -18.86 | -37.64 |
| Income/Loss From Continuing Operations Before Tax |
37.66%
-43.58
|
-31.66 | -24.70 | -40.52 | -53.22 |
| Income Tax Expense/Benefit, Deferred |
-
|
- | - | - | -4.939 |
| Income Tax Expense/Benefit |
121.53%
4.836
|
2.183 | -3.128 | 2.715 | -0.287 |
| Income/Loss From Continuing Operations After Tax |
43.07%
-48.42
|
-33.84 | -21.58 | -43.23 | -52.93 |
|
Net Income/Loss
|
43.07%
-48.42
|
-33.84 | -21.58 | -43.23 | -52.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
16,270%
302.90
|
1.8503 | 295.76 | 292.80 | 291.34 |
| Diluted Average Shares |
16,270%
302.90
|
1.8503 | 295.76 | 292.80 | 291.34 |
| Basic Earnings Per Share |
45.45%
-0.16
|
-0.11 | -0.07 | -0.15 | -0.18 |
| Diluted Earnings Per Share |
45.45%
-0.16
|
-0.11 | -0.07 | -0.15 | -0.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):